Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution.
Level 5 - mechanism / opinion, no new human data
Preclinical animal study using mouse tumor models.
PubMed 26895752 · doi:10.1016/j.cmet.2016.01.011
What was done
Tumor-bearing mice were randomized to voluntary wheel running or control across five distinct tumor models. The researchers conducted microarray profiling of tumors, measured natural killer (NK) cell infiltration, performed NK cell depletion experiments, and tested the mechanistic roles of epinephrine (via beta-adrenergic signaling blockade) and interleukin-6 (using IL-6-blocking antibodies).
What was found
Mice with access to voluntary wheel running achieved an over 60% reduction in tumor incidence and growth across five tumor models. Gene expression analysis showed upregulation of immune-related pathways in tumors from running mice. NK cell infiltration into tumors increased significantly with exercise, and depleting NK cells prevented exercise-induced tumor suppression. Blocking beta-adrenergic signaling or IL-6 blunted the exercise-mediated mobilization of NK cells, their intratumoral infiltration and activation, and the resulting tumor inhibition. Specific numerical values beyond the >60% reduction were not reported in the abstract.
Why it matters
This study defines a discrete physiological and immunological pathway—epinephrine- and IL-6-dependent NK cell mobilization and intratumoral infiltration—by which voluntary exercise suppresses tumor growth in preclinical models.
Limits
The study was conducted entirely in mice, so findings cannot be directly assumed to translate to human cancer biology. The abstract does not report sample sizes, specific tumor types evaluated, baseline characteristics, or exact statistical metrics such as confidence intervals or p-values.
Cited by
- supports Preclinical mouse models demonstrate that exercise increases the infiltration and numbers of T cells and natural killer cells within tumors.
- supports Preclinical animal trials demonstrate that exercise as a monotherapy slows the growth and metastatic spread of implanted cancer tumors in mice.